Latest filing published 21 May 2025 for Lytix Biopharma ASA.
Insider track record
No signal scores available.
The Board: trading record in brief
The Board discloses dealings in Lytix Biopharma ASA to Oslo Børs. The record holds 2 filings, for trades running from 14 December 2022 to 21 May 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 21 May 2025 came the latest disclosure, an option exercise in Lytix Biopharma ASA. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Companies and markets linked to The Board
Open company profiles for insider transactions, fundamentals and analyst consensus when available.